Abstract

Deubiquitinating enzymes are key regulators in the ubiquitin system and an emerging class of drug targets. These proteases disassemble polyubiquitin chains and many deubiquitinases show selectivity for specific polyubiquitin linkages. However, most biochemical insights originate from studies of single diubiquitin linkages in isolation, whereas in cells all linkages coexist. To better mimick this diubiquitin substrate competition, we develop a multiplexed mass spectrometry-based deubiquitinase assay that can probe all ubiquitin linkage types simultaneously to quantify deubiquitinase activity in the presence of all potential diubiquitin substrates. For this, all eight native diubiquitins are generated and each linkage type is designed with a distinct molecular weight by incorporating neutron-encoded amino acids. Overall, 22 deubiquitinases are profiled, providing a three-dimensional overview of deubiquitinase linkage selectivity over time and enzyme concentration.

Most insights into deubiquitinase (DUB) substrate specificity originate from studies with isolated di-ubiquitins (diUb), but in cells diUbs with different linkage types coexist. Here, the authors develop a mass spectrometric DUB activity assay that can probe all diUbs simultaneously under substrate competition conditions.

Details

Title
Neutron-encoded diubiquitins to profile linkage selectivity of deubiquitinating enzymes
Author
van Tol, Bianca D. M. 1   VIAFID ORCID Logo  ; van Doodewaerd, Bjorn R. 1 ; Lageveen-Kammeijer, Guinevere S. M. 2   VIAFID ORCID Logo  ; Jansen, Bas C. 2 ; Talavera Ormeño, Cami M. P. 1 ; Hekking, Paul J. M. 1 ; Sapmaz, Aysegul 1   VIAFID ORCID Logo  ; Kim, Robbert Q. 1   VIAFID ORCID Logo  ; Moutsiopoulou, Angeliki 1 ; Komander, David 3   VIAFID ORCID Logo  ; Wuhrer, Manfred 2   VIAFID ORCID Logo  ; van der Heden van Noort, Gerbrand J. 1   VIAFID ORCID Logo  ; Ovaa, Huib 1   VIAFID ORCID Logo  ; Geurink, Paul P. 1   VIAFID ORCID Logo 

 Leiden University Medical Center, Department of Cell and Chemical Biology, Chemical Biology and Drug Discovery, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978) 
 Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978) 
 Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Ubiquitin Signalling Division, Melbourne, Australia (GRID:grid.1042.7) (ISNI:0000 0004 0432 4889) 
Pages
1661
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2790694173
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.